iTeos Therapeutics CEO Michel Detheux's 2023 pay falls 45% to $5.8M
iTeos Therapeutics reports 2023 executive compensation
By ExecPay News
Published: April 25, 2024
iTeos Therapeutics reported fiscal year 2023 executive compensation information on April 25, 2024.
In 2023, three executives at iTeos Therapeutics received on average a compensation package of $3.8M, a 30% decrease compared to previous year.
Average pay of disclosed executives at iTeos Therapeutics
Michel Detheux, Chief Executive Officer, received $5.8M in total, which decreased by 45% compared to 2022. 77% of Detheux's compensation, or $4.4M, was in option awards. Detheux also received $385K in non-equity incentive plan, $579K in salary, $295K in stock awards, as well as $80K in other compensation.
Matthew Call, Chief Operating Officer, received a compensation package of $2.8M, which decreased by 2% compared to previous year. 59% of the compensation package, or $1.7M, was in option awards.
Matthew Gall, Chief Financial Officer, earned $2.7M in 2023.
Related executives
You may also like
Source: SEC filing on April 25, 2024.